The Nrf2 in Obesity: A Friend or Foe?

Overview

Journal Antioxidants (Basel)

Date 2022 Oct 27

PMID 36290791

Authors

Yudong Xia

Xiaoying Zhai

Yanning Qiu

Xuemei Lu

Yi Jiao

Affiliations

Soon will be listed here.

Abstract

Obesity and its complications have become serious global health concerns recently and increasing work has been carried out to explicate the underlying mechanism of the disease development. The recognized correlations suggest oxidative stress and inflammation in expanding adipose tissue with excessive fat accumulation play important roles in the pathogenesis of obesity, as well as its associated metabolic syndromes. In adipose tissue, obesity-mediated insulin resistance strongly correlates with increased oxidative stress and inflammation. Nuclear factor erythroid 2-related factor 2 (Nrf2) has been described as a key modulator of antioxidant signaling, which regulates the transcription of various genes coding antioxidant enzymes and cytoprotective proteins. Furthermore, an increasing number of studies have demonstrated that Nrf2 is a pivotal target of obesity and its related metabolic disorders. However, its effects are controversial and even contradictory. This review aims to clarify the complicated interplay among Nrf2, oxidative stress, lipid metabolism, insulin signaling and chronic inflammation in obesity. Elucidating the implications of Nrf2 modulation on obesity would provide novel insights for potential therapeutic approaches in obesity and its comorbidities.

Citing Articles

The protective effects of fisetin in metabolic disorders: a focus on oxidative stress and associated events.

Sattari M, Amri J, Shahaboddin M, Sattari M, Tabatabaei-Malazy O, Azmon M J Diabetes Metab Disord. 2024; 23(2):1753-1771.

PMID: 39610486 PMC: 11599505. DOI: 10.1007/s40200-024-01502-7.

Maternal Obesity Alters Placental and Umbilical Cord Plasma Oxidative Stress, a Cross-Sectional Study.

Jantape T, Kongwattanakul K, Arribas S, Rodriguez-Rodriguez P, Iampanichakul M, Settheetham-Ishida W Int J Mol Sci. 2024; 25(19).

PMID: 39409195 PMC: 11477106. DOI: 10.3390/ijms251910866.

Medicinal Plant Extracts against Cardiometabolic Risk Factors Associated with Obesity: Molecular Mechanisms and Therapeutic Targets.

Gutierrez-Cuevas J, Lopez-Cifuentes D, Sandoval-Rodriguez A, Garcia-Banuelos J, Armendariz-Borunda J Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065815 PMC: 11280341. DOI: 10.3390/ph17070967.

The Bioactivity and Phytochemicals of (), a Plant of Multiple Pharmacological Activities.

Jaiswal V, Lee H Int J Mol Sci. 2024; 25(5).

PMID: 38473839 PMC: 10931824. DOI: 10.3390/ijms25052592.

Metformin plus L-carnitine enhances brown/beige adipose tissue activity via Nrf2/HO-1 signaling to reduce lipid accumulation and inflammation in murine obesity.

Liang G, Fang J, Zhang P, Ding S, Zhao Y, Feng Y Open Med (Wars). 2024; 19(1):20240900.

PMID: 38463531 PMC: 10921440. DOI: 10.1515/med-2024-0900.

References

Kim S, Sohn I, Ahn J, Lee K, Lee Y, Lee Y . Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene. 2004; 340(1):99-109. DOI: 10.1016/j.gene.2004.06.015. View

Chartoumpekis D, Palliyaguru D, Wakabayashi N, Fazzari M, Khoo N, Schopfer F . Nrf2 deletion from adipocytes, but not hepatocytes, potentiates systemic metabolic dysfunction after long-term high-fat diet-induced obesity in mice. Am J Physiol Endocrinol Metab. 2018; 315(2):E180-E195. PMC: 6139497. DOI: 10.1152/ajpendo.00311.2017. View

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

Zhu Q, An Y, Kim M, Zhang Z, Zhao S, Zhu Y . Suppressing adipocyte inflammation promotes insulin resistance in mice. Mol Metab. 2020; 39:101010. PMC: 7272509. DOI: 10.1016/j.molmet.2020.101010. View

Prasad M, Chen E, Toh S, Gascoigne N . Autoimmune responses and inflammation in type 2 diabetes. J Leukoc Biol. 2020; 107(5):739-748. DOI: 10.1002/JLB.3MR0220-243R. View

Nagashimada M, Sawamoto K, Ni Y, Kitade H, Nagata N, Xu L . CX3CL1-CX3CR1 Signaling Deficiency Exacerbates Obesity-induced Inflammation and Insulin Resistance in Male Mice. Endocrinology. 2021; 162(6). DOI: 10.1210/endocr/bqab064. View

Chartoumpekis D, Yagishita Y, Fazzari M, Palliyaguru D, Rao U, Zaravinos A . Nrf2 prevents Notch-induced insulin resistance and tumorigenesis in mice. JCI Insight. 2018; 3(5). PMC: 5922294. DOI: 10.1172/jci.insight.97735. View

Wharton S, Lau D, Vallis M, Sharma A, Biertho L, Campbell-Scherer D . Obesity in adults: a clinical practice guideline. CMAJ. 2020; 192(31):E875-E891. PMC: 7828878. DOI: 10.1503/cmaj.191707. View

Aslam M, Hahn V, Jani V, Hsu S, Sharma K, Kass D . Reduced Right Ventricular Sarcomere Contractility in Heart Failure With Preserved Ejection Fraction and Severe Obesity. Circulation. 2020; 143(9):965-967. PMC: 7920934. DOI: 10.1161/CIRCULATIONAHA.120.052414. View

10.

Zhao Y, Qin P, Sun H, Liu Y, Liu D, Zhou Q . Metabolically healthy general and abdominal obesity are associated with increased risk of hypertension. Br J Nutr. 2019; 123(5):583-591. DOI: 10.1017/S0007114519003143. View

11.

Wang Z, Zuo Z, Li L, Ren S, Gao T, Fu J . Nrf2 in adipocytes. Arch Pharm Res. 2020; 43(3):350-360. DOI: 10.1007/s12272-020-01227-0. View

12.

Tanaka Y, Aleksunes L, Yeager R, Gyamfi M, Esterly N, Guo G . NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J Pharmacol Exp Ther. 2008; 325(2):655-64. DOI: 10.1124/jpet.107.135822. View

13.

Xu J, Shimpi P, Armstrong L, Salter D, Slitt A . PFOS induces adipogenesis and glucose uptake in association with activation of Nrf2 signaling pathway. Toxicol Appl Pharmacol. 2015; 290:21-30. PMC: 4742372. DOI: 10.1016/j.taap.2015.11.002. View

14.

Kang B, Kim C, Hwang J, Jo K, Kim S, Suh H . Punicalagin, a Pomegranate-Derived Ellagitannin, Suppresses Obesity and Obesity-Induced Inflammatory Responses Via the Nrf2/Keap1 Signaling Pathway. Mol Nutr Food Res. 2019; 63(22):e1900574. DOI: 10.1002/mnfr.201900574. View

15.

Kobayashi A, Kang M, Okawa H, Ohtsuji M, Zenke Y, Chiba T . Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol. 2004; 24(16):7130-9. PMC: 479737. DOI: 10.1128/MCB.24.16.7130-7139.2004. View

16.

Forman H, Zhang H . Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021; 20(9):689-709. PMC: 8243062. DOI: 10.1038/s41573-021-00233-1. View

17.

Tam B, Morais J, Santosa S . Obesity and ageing: Two sides of the same coin. Obes Rev. 2020; 21(4):e12991. DOI: 10.1111/obr.12991. View

18.

Guo C, Bi J, Li X, Lyu J, Liu X, Wu X . Immunomodulation effects of polyphenols from thinned peach treated by different drying methods on RAW264.7 cells through the NF-κB and Nrf2 pathways. Food Chem. 2020; 340:127931. DOI: 10.1016/j.foodchem.2020.127931. View

19.

Azzimato V, Jager J, Chen P, Morgantini C, Levi L, Barreby E . Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance. Sci Transl Med. 2020; 12(532). DOI: 10.1126/scitranslmed.aaw9709. View

20.

Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S . Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet. 2003; 35(3):238-45. DOI: 10.1038/ng1248. View